SERRA, Pietro
 Distribuzione geografica
Continente #
NA - Nord America 2.146
EU - Europa 437
AS - Asia 336
SA - Sud America 27
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.954
Nazione #
US - Stati Uniti d'America 2.134
SG - Singapore 148
SE - Svezia 103
IN - India 99
IT - Italia 93
UA - Ucraina 88
CN - Cina 84
FI - Finlandia 67
AR - Argentina 26
DE - Germania 18
GB - Regno Unito 16
RU - Federazione Russa 14
IE - Irlanda 12
RO - Romania 12
CA - Canada 10
BE - Belgio 6
TG - Togo 6
BG - Bulgaria 4
CH - Svizzera 2
IR - Iran 2
MX - Messico 2
NL - Olanda 2
AZ - Azerbaigian 1
CL - Cile 1
DZ - Algeria 1
EU - Europa 1
HK - Hong Kong 1
KG - Kirghizistan 1
Totale 2.954
Città #
Fairfield 270
Chandler 198
Woodbridge 166
Ashburn 140
Santa Clara 129
Dearborn 126
Ann Arbor 124
Seattle 111
Wilmington 106
Singapore 101
Houston 94
Cambridge 88
San Paolo di Civitate 73
Princeton 61
Plano 55
Boston 49
Lawrence 49
Beijing 44
Jacksonville 31
San Diego 26
Federal 25
Andover 21
Falls Church 17
Boardman 16
Des Moines 14
Helsinki 14
Millbury 13
Dublin 11
Rome 11
Norwalk 9
Toronto 7
Brussels 6
Lomé 6
Falkenstein 5
Hefei 5
Kunming 5
Moscow 5
Los Angeles 4
Mannheim 4
Nanjing 4
Sofia 4
Bühl 3
Guangzhou 3
Laurel 3
Ottawa 3
San Mateo 3
Bern 2
Chengdu 2
Fort Worth 2
Fuzhou 2
Mexico City 2
Nanchang 2
Springfield 2
Verona 2
Zanjan 2
Algiers 1
Auburn Hills 1
Baku 1
Bielefeld 1
Bishkek 1
Bologna 1
Bremen 1
Changsha 1
Chions 1
Dallas 1
Fremont 1
Grafing 1
Guiyang 1
Hangzhou 1
Harbin 1
Hebei 1
Hong Kong 1
Hounslow 1
Indiana 1
Jiaxing 1
Jinan 1
Las Vegas 1
Leawood 1
Letterkenny 1
London 1
Mcallen 1
Milan 1
Nottingham 1
Plattsmouth 1
Pomezia 1
Provo 1
Quzhou 1
Redmond 1
Shanghai 1
Southend 1
Tappahannock 1
Washington 1
Xian 1
Zhengzhou 1
Totale 2.319
Nome #
Aorto-femoral graft infections: a clinical and microbiological analysis. 104
Circulating CD34+ cells are decreased in chronic obstructive pulmonary disease 93
Exogenous lipids clearance in cirrhotic patients 89
ATRIAL NATRIURETIC PEPTIDE, RENIN AND ALDOSTERONE IN OBSTRUCTIVE LUNG-DISEASE AND HEART-FAILURE 81
Non-invasive evaluation of gas exchange during a shuttle walking test vs. a 6-min walking test to assess exercise tolerance in COPD patients 76
Antimicrobial susceptibilities of Streptococcus species that cause septicemia in neutropenic patients. 75
Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. 75
Conservative medical therapy of prosthetic joint infections: retrospective analysis of an 8-year experience 75
Exogenous lipid clearance in compensated liver cirrhosis 74
Brain Dysfunction in Respiratory Failure 73
EFFECTS OF FENOTEROL ON OXYGEN-TRANSPORT IN PATIENTS WITH CHRONIC AIR-FLOW OBSTRUCTION 72
Pathophysiological adaptations to walking and cycling in primary pulmonary hypertension 71
Arthritis as a rare side effect of phenytoin therapy. 69
Production of plasminogen activator and plasminogen activator inhibitors by alveolar macrophages in control subjects and AIDS patients 68
Health care associated pneumonia: a new clinical entity. 68
Staphylococcus aureus bacteremia in patients with hematologic malignancies: a retrospective case-control study 67
Role of multidrug-resistant pathogens in health-care-associated pneumonia 67
Cytomegalovirus in bronchoalveolar lavage specimens from patients with AIDS: comparison with antigenaemia and viraemia 66
Effect of reduced body weight on muscle aerobic capacity in patients with COPD 66
OXYGEN EFFECT ON O-2 DEFICIT AND VO2 KINETICS DURING EXERCISE IN OBSTRUCTIVE PULMONARY-DISEASE 64
Aortofemoral graft infection: the usefulness of 99mTC-HMPAO-labelled leukocyte scan. 64
EFFECT OF INORGANIC-PHOSPHATE IN HYPOXEMIC CHRONIC OBSTRUCTIVE LUNG-DISEASE PATIENTS DURING EXERCISE 61
Performance of PSI, CURB-65, and SCAP scores in predicting the outcome of patients with community-acquired and healthcare-associated pneumonia 60
Circadian rhythm of the autonomic nervous system in insulin resistant subjects with normoglycemia, impaired fasting glycemia, impaired glucose tolerance, type 2 diabetes mellitus 59
The correlation among QTc interval, hyperglycaemia and the impaired autonomic activity 57
A case of brain abscess due to Brucella melitensis. 56
Successful treatment of disseminated cerebritis complicating methicillin-resistant staphylococcus aureus endocarditis unresponsive to vancomycin therapy with linezolid 55
REGULATION OF ATRIAL-NATRIURETIC-PEPTIDE RELEASE IN NORMAL HUMANS 55
CARDIOPULMONARY EXERCISE TESTING IN THE EVALUATION OF PATIENTS WITH VENTILATORY VS CIRCULATORY CAUSES OF REDUCED EXERCISE TOLERANCE 55
Non-tubercular and non-brucellar spondylodiscitis: preliminary clinico-microbiologic analysis of 37 cases 54
CD4+ T-lymphocitopenia and Pneumocistis carinii pneumonia in a patient with miliary tuberculosis 51
Incidence of acid-base and electrolyte disturbances in a general hospital: a study of 110 consecutive admissions. 51
EFFECT OF OXYGEN ON NA+ EXCRETION IN HYPOXEMIC CHRONIC OBSTRUCTIVE LUNG-DISEASE (COLD) PATIENTS 50
NUTRITIONAL STATE AND EXERCISE TOLERANCE IN PATIENTS WITH COPD 47
[Relapsing polychondritis: a case with anticartilage, anticardiolipin and anticentromere antibodies]. 47
Alveolar cell population in HIV infected patients 46
ATRIAL NATRIURETIC PEPTIDE (ANP) RESPONSE TO INTRATHORACIC PRESSURE (ITP)ELEVATION IN CHRONIC OBSTRUCTIVE LUNG-DISEASE (COLD) AND IN CHRONIC HEART-DISEASE (CHD) PATIENTS 45
[Study of bronchoalveolar lavage in febrile patients with AIDS or AIDS-related syndrome]. 45
EFFECT OF POSITIVE AND NEGATIVE-PRESSURE BREATHING ON SODIUM AND WATER-EXCRETION 42
[A combination of fenoterol and ipratropium bromide administered by inhalation. Evaluation of its effectiveness and tolerance in a long-term study]. 42
Circadian rhythm of autonomic activity in non diabetic offsprings of type 2 diabetic patients 41
COMPARISON OF CARDIORESPIRATORY RESPONSES TO O-2 AT REST AND EXERCISE - HYPERCAPNIC VS NORMOCAPNIC OBSTRUCTIVE LUNG-DISEASE PATIENTS 40
EFFECT OF OXYGEN ON O2 KINETICS AND OTHER CARDIORESPIRATORY PARAMETERS DURING EXERCISE IN COPD 40
TOLERANCE TO INHALED DUOVENT - A LONG-TERM STUDY 37
MODULATION OF ATRIAL NATRIURETIC PEPTIDE RELEASE IN NORMALS 37
PHARMACOLOGICAL ELEVATION OF PLASMA INORGANIC-PHOSPHATE IN HYPOXEMIC OBSTRUCTIVE LUNG-DISEASE 37
Urokinase plasminogen activator and TGF-beta production in immunosuppressed patients with and without Pneumocystis carinii. 37
PLASMA ATRIAL NATRIURETIC PEPTIDE (ANP), RENIN-ACTIVITY (PRA), AND ALDOSTERONE (PA) IN CHRONIC OBSTRUCTIVE LUNG-DISEASE (COLD) 36
Plasminogen activator production in a rat model of Pneumocystis carinii pneumonae 33
EFFECT OF POSITIVE AND NEGATIVE-PRESSURE BREATHING ON RENAL SODIUM AND WATER-EXCRETION 32
The effect of body weight and arterial hypoxemia on peak oxygen uptake (VO2 peak) and VO2 kinetics (tau VO2) in COPD. 31
Pulmonary gas exchange and exercise capacity in patients with systemic lupus erythematosus 29
Pharmacologic elevation of blood inorganic phosphate (Pi) in hypoxemic patients with COPD. 26
A bitter pill to swallow: adjustments to oral contraceptive pill use in polycystic ovary syndrome 7
Totale 2.998
Categoria #
all - tutte 8.729
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.729


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020352 0 0 0 0 0 0 106 80 66 49 36 15
2020/2021151 21 22 7 15 4 6 2 20 19 19 13 3
2021/2022566 1 31 56 32 63 12 13 55 56 42 77 128
2022/2023630 113 181 41 77 62 59 6 25 46 4 11 5
2023/2024157 22 31 4 11 11 6 1 6 0 30 17 18
2024/2025293 25 19 60 9 119 61 0 0 0 0 0 0
Totale 2.998